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White HM, Acton AJ, Kamocka MM, Considine RV. Hepato-
cyte growth factor regulates neovascularization in developing fat
pads. Am J Physiol Endocrinol Metab 306: E189–E196, 2014. First
published December 3, 2013; doi:10.1152/ajpendo.00394.2013.—In
this study, we used lentiviral-delivered shRNA to generate a clonal
line of 3T3-F442A preadipocytes with stable silencing of hepatocyte
growth factor (HGF) expression and examined the long-term conse-
quence of this modification on fat pad development. HGF mRNA
expression was reduced 94%, and HGF secretion 79% (P  0.01),
compared with preadipocytes treated with nontargeting shRNA. Fat
pads derived from HGF knockdown preadipocytes were significantly
smaller (P 0.01) than control pads beginning at 3 days postinjection
(0.022  0.003 vs. 0.037  0.004 g), and further decreased in size at
day 7 (0.015 0.004 vs. 0.037 0.003 g) and day 14 (0.008 0.002
vs. 0.045  0.007 g). Expression of the endothelial cell genes TIE1
and PECAM1 increased over time in control fat pads (1.6  0.4 vs.
11.4  1.7 relative units at day 3 and 14, respectively; P  0.05) but
not in HGF knockdown fat pads (1.1 0.5 vs. 5.9 2.2 relative units
at day 3 and 14). Contiguous vascular structures were observed in
control fat pads but were much less developed in HGF knockdown fat
pads. Differentiation of preadipocytes to mature adipocytes was sig-
nificantly attenuated in HGF knockdown fat pads. Fat pads derived
from preadipocytes with knockdown of the HGF receptor c-MET
were smaller than control pads at day 3 postinjection (0.034  0.002
vs. 0.049  0.004 g; P  0.05), and remained the same size through
day 14. c-MET knockdown fat pads developed a robust vasculature,
and preadipocytes differentiated to mature adipocytes. Overall these
data suggest that preadipocyte-secreted HGF is an important regulator
of neovascularization in developing fat pads.
neovascularization; 3T3-F442A; TIE-1; PECAM-1; peroxisome pro-
liferator-activated receptor-; lipoprotein lipase
THERE IS INTENSE INTEREST in understanding the function of the
adipose tissue vasculature in health and disease. It is known
that angiogenesis is required to support the substantial growth
potential of adipose tissue and that angiogenesis plays a critical
role in the development of obesity (8, 20, 31). On the other
hand, a number of studies have suggested that in obesity the
adipose tissue is hypoxic, either due to rarefaction or insuffi-
cient blood flow, and that adipose tissue hypoxia is a root cause
of the chronic inflammation characteristic of obesity (28, 31).
In related areas of inquiry, studies to understand adipocyte-
regulated vascular growth are expected to provide novel insight
into the mechanisms responsible for the greater risk of cancer
in obese subjects (27), and there continues to be an active
interest in targeting the adipose tissue vasculature as a means
of treating and/or preventing obesity (5, 13, 34).
Our laboratory is investigating the role of hepatocyte growth
factor (HGF), a potent angiogenic and mitogenic factor, in the
regulation of adipose tissue vascular growth. We have shown
that both adipocytes and preadipocytes secrete HGF, that
circulating HGF is elevated in obese humans, and that weight
loss decreases HGF (2, 29). Using the 3T3-F442A in vivo fat
pad formation model, we previously observed that preadi-
pocyte HGF expression regulates early neovascular events in
fat pads that develop following injection of preadipocytes
under the skin of BALB/c nude mice (1). In that study we used
an electroporation technique to deliver small-interfering RNA
(siRNA) targeting HGF into 3T3-F442A cells, achieving a
transient 82% knockdown of HGF mRNA and protein secre-
tion. At 72 h postinjection, mRNA for the endothelial cell
markers tyrosine kinase with immunoglobulin-like and epider-
mal growth factor-like domains 1 (TIE1) and platelet endothe-
lial cell adhesion molecule 1 (PECAM1) was significantly
reduced in fat pads derived from preadipocytes with HGF
knockdown compared with that in fat pads from control prea-
dipocytes. Immunohistochemical staining demonstrated more
endothelial cells in the muscle layer next to fat pads derived
from control 3T3-F442A cells than in those with HGF knock-
down, but neither endothelial cells nor vascular structures were
detected by immunohistochemistry in the center of injected
preadipocytes. We concluded from these findings that preadi-
pocyte HGF expression was required for early neovasculariza-
tion of developing fat pads, but a number of questions re-
mained unanswered. The long-term effects of silencing HGF in
developing fat pads could not be tested because of the transient
nature of the HGF knockdown achieved with electroporated
siRNA. The effect of HGF knockdown on the size of devel-
oping fat pads was not quantitated, and the formation of mature
vascular structures within the fat pad was not observed. Fi-
nally, adipocytes express the HGF receptor c-MET (3), and
given that an autocrine effect of HGF on cell survival has been
observed (15), it remains to be established if loss of autocrine/
paracrine signaling to preadipocytes impairs fat pad develop-
ment.
In the current study, we used lentiviral-delivered short-
hairpin loop siRNA to induce stable HGF silencing in 3T3-
F442A preadipocytes and examined the long-term conse-
quences on fat pad development. Based on our observations
suggesting that preadipocyte HGF knockdown had acute ef-
fects on vascular recruitment to the developing fat pad, we
hypothesized that establishment of viable fat pads containing
mature adipocytes would be inhibited when derived from
preadipocytes lacking HGF. We also hypothesized that loss of
autocrine HGF signaling via c-MET in preadipocytes would
not impair fat pad development to the same degree as loss of
HGF.
MATERIALS AND METHODS
Silencing HGF and c-MET expression. 3T3-F442A preadipocytes
at 70% confluence were treated with lentiviral shRNA reagents
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targeting either murine HGF or c-MET, or with a scrambled shRNA
that did not match any mouse gene, following the manufacturer’s
protocol (Mission TRC shRNA Lentiviral Target Set; Sigma Aldrich,
St. Louis, MO). After selection with puromycin, surviving clones
were screened for mRNA knockdown. Of the five HGF-targeted
lentiviral clones tested, maximal knockdown was achieved with clone
TRCN0000031279 (CCGGCCTGAAGATACTTGAATGAATCTC-
GAGATTCATTCAAGTATCTTCAGGTTTTTG). Clone TCN000-
0023531 (CCGGCCCGACGTGAACACATTTGATCTCGAGAT-
CAAATGTGTTCACGTCG) targeting c-MET provided the best knock-
down of this target gene. The selected preadipocyte lines were expanded in
DMEM  10% bovine calf serum (BCS), and aliquots were frozen.
Cell culture. Preadipocytes were maintained in DMEM  10%
BCS. For differentiation culture medium was changed to DMEM 
10% fetal bovine serum with 10 g/ml insulin (Sigma-Aldrich) for 8
days. HGF secretion from cultured cells was measured using a
mouse-specific HGF ELISA (Raybiotech, Norcross, GA). Secretion
was normalized to cell DNA on the dish determined using the
PicoGreen dsDNA kit (Life Technologies, Grand Island, NY).
Western blotting. Membrane-bound proteins were extracted from
siNON, siMET, and HEK293 (positive control) cell lysates using the
Mem-PER Plus Protein Extraction Kit per the manufacturer’s protocol
(Thermo Fisher Scientific, Waltham, MA). The protein concentration
was determined by BCA protein assay (Pierce, Rockford, IL). Protein
lysates (75 g) and Precision Plus Western C standard with Strep-
Tactin horseradish peroxidase (HRP) conjugate secondary antibody
(Bio-Rad, Hercules, CA) were separated on a 4–16% gradient gel and
transferred to a polyvinylidene fluoride membrane. The membrane
was blocked (1 TBS, 0.1% Tween 20, and 5% nonfat dry milk) for
2 h at room temperature and then incubated with mouse monoclonal
antibody to Met (ab3127; Cell Signaling Technology, Boston, MA)
diluted (1:1,000) in blocking solution overnight at 4°C with gentle
shaking. After being washed, the membrane was exposed to donkey
anti-mouse IgG-HRP secondary antibody (ab97080; Abcam, Cam-
bridge, MA) diluted (1:5,000) for 1 h at room temperature. The
membrane was washed and protein was detected using Super Signal
(ThermoScientific, Hanover Park, IL) and visualized by a ChemiDoc
(Bio-Rad). Exposure times adequate to visualize Met bands resulted in
oversaturation of Western C standard; therefore, ChemiDoc Image
Lab software (Bio-Rad) was used to merge the ladder image from a
less-exposed capture (10 s) onto a longer-exposed capture (450 s).
ChemiDoc Image Lab software (Bio-Rad) was also used for quanti-
fication of band intensity. Equivalent protein loading was verified by
quantitation of the nonspecific band density at 70 kDa (siNON:
8,890,880; siMET: 8,854,677; HEK293: 8,757,140).
Fat pad formation in vivo. Undifferentiated preadipocytes were
trypsinized from the flasks and washed with culture medium. Cells
(1.5 X 107) in 0.05 ml DMEM  10% BCS were injected just under
the skin on the back of 8- to 10-wk-old male BALB/c athymic nude
mice (Charles River Laboratories, Wilmington, MA). Each mouse
received an injection of nontargeted preadipocytes (siNON) with
either HGF knockdown (siHGF) or c-MET knockdown (siMET)
preadipocytes on the opposite side of the spine. In some cases mice
received injections of all three types of preadipocytes such that two fat
pads were formed on the same side of the spine with one more dorsal
and the other more ventral. When growing two fat pads on the same
side of the spine, injections were randomized. Animal use was
approved by the Indiana University School of Medicine Institutional
Animal Care and Use Committee.
Real-time RT-PCR. Isolation of RNA, primers for peroxisome
proliferator-activated receptor- (PPAR), lipoprotein lipase (LPL),
TIE1, and PECAM1, and methods for real-time PCR have been
previously described (1) except that an ABI Prism 7300 Sequence
Detection System (Applied Biosystems, Foster City, CA) was used for
the current study. Primers for murine preadipocyte factor 1 (Pref-1)
(30), vascular endothelial growth factor (VEGF) (25), hypoxia-induc-
ible factor-1	 (HIF-1	) (19), CD-68 (37), BAX (35), and CHOP (22)
were from the literature. Primers for c-MET were forward 5=-GAAT-
GTCGTCCTACACGGCC-3= and reverse 5=-CACTACACAGTCAG-
GACACTGC-3=. Gene expression was normalized to 36B4 [mouse
acidic ribosomal phosphoprotein (1)] expression using the delta CT
method. There was no difference in 36B4 expression in 3T3-F442A
preadipocytes or adipocytes following differentiation in vitro or in vivo.
Confocal microscopy. Confocal imaging was performed on grow-
ing fat pads to obtain qualitative information on vascular and fat cell
development using the method of Nishimura et al. (26). Fat pads were
removed and stained with BODIPY 558/568 dodecanoic acid and
isolectin G5-IB4 conjugated to Alexa Fluor 488 (Molecular Probes,
Life Technologies). Confocal images of whole tissue mounts were
acquired with a confocal/two-photon Olympus Fluoview FV-1000
MPE system (Olympus America, Central Valley, PA) available at the
Indiana Center for Biological Microscopy facility (Indianapolis, IN),
using an Olympus XLUMPLFL 20, NA 0.95 water-immersion
objective. Images were collected in a sequential illumination mode
using 488- and 559-nm laser lines while fluorescent emission was
collected in two spectral detectors with filter range set up to 500–545
nm for green dye and 570–670 nm for red dye. Series of sections
through the depth of tissue (Z-stacks) were collected using optimal
step size settings with images comprised of 512  512 pixels (634 
634 m2). Projection images of 33-m-thick Z-stacks were created
using MetaMorph imaging software (Molecular Devices, Downing-
town, PA).
Statistical analyses. All data are expressed as means  SE. Statis-
tical comparison of differentiation in vitro was done by paired t-test.
Comparison of gene expression and protein secretion in the three
preadipocyte cell lines, or in fat pads derived from the three cell lines,
was done by two-tailed unpaired t-test for normally distributed data
and by two-tailed Mann-Whitney test for data not normally distrib-
uted. Effect of time on fat pad weight and gene expression was
assessed by one-way analysis of variance followed by Tukey’s Mul-
tiple-Comparison Test. Means were considered significantly different
when P  0.05. All analyses were done using GraphPad Prism
Version 5.
RESULTS
Silencing HGF expression impairs fat pad development. A
3T3-F442A preadipocyte cell line in which HGF expression
was silenced (siHGF) was derived by treatment with lentiviral-
driven shRNA, antibiotic selection, and cloning using standard
techniques. A control preadipocyte cell line (siNON) was
derived by identical techniques using a nontargeting lentiviral
shRNA. A 94% reduction in HGF mRNA was achieved (0.2
0.01 vs. 2.8  0.6 relative units; n 
 6; P  0.01). HGF
secretion from siHGF preadipocytes in vitro was reduced by
79% compared with siNON preadipocytes (17.7 9.9 vs. 85.2
8.2 ng HGF·g DNA1·48 h1; n 
 4, P  0.01). Lentiviral-
treated preadipocytes readily differentiated in vitro. In siNON
preadipocytes, PPAR expression increased 9 2-fold (2.4 1.2
to 11.8 3.6 relative units, n
 7, P 0.02) and LPL expression
increased 11  3-fold (10.0  2.8 to 73.8  7.9 relative units;
P  0.005) at day 8 compared with day 0. In siHGF preadi-
pocytes, differentiated in vitro PPAR expression increased 13
4-fold (0.3 0.1 to 2.5 0.6 relative units, n
 8; P 0.01), and
LPL expression increased 54  19-fold (1.3  0.3 to 36.1  9.9
relative units; P  0.005).
siNON preadipocytes injected under the skin of nude mice
formed readily identifiable fat pads that were contained within
a connective tissue pocket, as previously observed (1). The
weight of siNON fat pads did not change over the course of the
14-day observation period (Fig. 1). In contrast, siHGF fat pads
were significantly smaller (P  0.01) than siNON fat pads
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beginning at day 3, with siHGF fat pad size continuing to
decrease over time. At 7 days postinjection, siHGF fat pads
could not be identified in two of seven mice. At 14 days fat
pads could not be found in 4 of 13 siHGF-injected mice. The
mean weight of the siHGF fat pads shown in Fig. 1 was
calculated using only the weight of fat pads recovered at each
time point.
Markers of preadipocyte differentiation to mature adipocytes
increased over time in siNON fat pads. PPAR and LPL
expression was significantly greater (P  0.05) at 14 days
compared with that at 3 days (Fig. 2). In contrast, expression of
PPAR and LPL in siHGF fat pads did not increase over time,
and was significantly less (P  0.02) than that of siNON fat
pads at all times, indicating a failure of the preadipocytes to
differentiate in vivo. Expression of the preadipocyte marker
Pref-1 decreased in siNON fat pads by day 14. Pref-1 was
higher in siHGF fat pads and did not change over the course of
the experiment.
Expression of the endothelial cell-specific genes TIE-1 and
PECAM-1 increased over time in fat pads from siNON pre-
adipocytes such that expression at day 14 was significantly
greater than that at day 3 (Fig. 3). In siHGF fat pads, TIE-1
mRNA expression did not differ over time and was signifi-
cantly less (P  0.05) than that in siNON fat pads at day 14.
PECAM-1 expression in siHGF fat pads increased over time
but remained significantly less than that in siNON fat pads at
day 14. Confocal microscopic images of a representative si-
NON and siHGF fat pad are shown in Fig. 4. A contiguous
vasculature and large lipid-filled adipocytes are readily noted
in the siNON fat pad. In contrast, endothelial cell staining is
detectable in the siHGF fat pad, but functional capillaries do
not appear to be present. Some lipid-filled adipocytes are
present, but these are smaller and much fewer in number than
in the control fat pad.
To probe possible mechanisms through which loss of prea-
dipocyte HGF resulted in impaired fat pad development, we
examined expression of several additional genes in fat pads at
72 h postinjection. HIF-1	 was significantly greater in siHGF
than siNON fat pads (Fig. 5). There was no difference in
expression of VEGF (9.5  1.5 vs. 9.4  1.3), CD68 (17.9 
4.4 vs. 19.4  4.4), CHOP (9.6  0.9 vs. 9.3  1.5), or BAX
(2.5  0.3 vs. 2.8  0.1 relative units) between siNON and
siHGF fat pads at 3 days postinjection.
Preadipocytes with reduced HGF receptor c-MET expres-
sion form fat pads. A 3T3-F442A preadipocyte cell line in
which c-MET expression was knocked down (siMET) was
derived by the same procedures used to knockout HGF expres-
sion. A 40% reduction in c-MET mRNA was achieved (1.3 
0.2 vs. 2.2  0.4 relative units; n 
 6; P  0.05), which
decreased c-MET protein 44% (Fig. 6). HGF secretion from
siMET preadipocytes in vitro was increased to 280% of that
from siNON preadipocytes (239.0  4.4 vs. 85.2  8.2 ng
HGF·g DNA1·48 h1; n 
 4, P  0.01). In siMET preadi-
pocytes differentiated in vitro, PPAR expression increased
Fig. 2. Inhibition of preadipocyte HGF expression impairs differentiation to
mature adipocytes in vivo. In siNON fat pads, expression of adipocyte markers
peroxisome proliferator-activated receptor- (PPAR) and lipoprotein lipase
(LPL) is greater at day 14 compared with day 3, and expression of the
preadipocyte marker preadipocyte factor 1 (Pref-1) mRNA is less at day 14
than day 3. In siHGF fat pads, markers of adipocyte maturity do not increase
with time and are significantly less than that in siNON fat pads. Pref-1 in
siHGF fat pads is greater than that in siNON fat pads all time points and does
not decrease over time. Values represent means  SE for the no. of fat pads
described in Fig. 1. #P  0.05 compared with day 3 fat pad; *P  0.02
compared with siNON fat pad at that time point.
Fig. 1. Lack of preadipocyte hepatocyte growth factor (HGF) expression
reduces size of developing fat pads. 3T3-F442A preadipocytes with HGF
knockdown (siHGF) and control preadipocytes (siNON) were injected under
the skin of nude mice, and developing fat pads were removed and weighed on
the indicated day postinjection. Values represent means  SE for n 
 13
siNON and siHGF fat pads at day 3; n
 7 siNON and 5 siHGF fat pads at day
7 (2 siHGF pads not found); and n 
 13 siNON and 9 siHGF fat pads at day
14 (4 siHGF pads not found). *P  0.01 compared with siNON fat pad at that
time point.
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109  37-fold (0.04  0.01 to 3.9  1.8 relative units, n 
 8,
P  0.001), and LPL expression increased 72  25-fold (2.7 
1.5 to 50.8  6.1 relative units; P  0.001).
In this series of experiments, the size of siNON fat pads was
significantly larger at day 14 than day 7 (Fig. 7). In contrast to
the effect of HGF knockdown to result in progressively smaller
fat pads, the weight of siMET fat pads did not change over the
14-day time period. However, siMET fat pad weight was
significantly less (P  0.05) than that of the siNON fat pads at
day 3 and day 14 (Fig. 7).
In both siNON and siMET fat pads PPAR and LPL
expression increased over time and was significantly greater
(P  0.05) at 14 days compared with that at 3 days (Fig. 8).
Expression of PPAR and LPL in siMET pads was signifi-
cantly less than that in siNON fat pads (P 0.05) at most time
points, which might be explained by the lower expression of
these transcription factors in siMET preadipocytes before in-
jection (see above in vitro differentiation data). Despite lower
levels in siMET preadipocytes, PPAR expression in siMET
fat pads increased 55 17-fold from day 3 to day 14 compared
with a 5 1-fold increase in siNON pads (P 0.05). The fold
increase in LPL expression in siMET fat pads was similar to
that in siNON fat pads (11  4 vs. 20  7; P  0.05). In both
siNON and siMET fat pads Pref-1 decreased over time such that
expression at day 14 was significantly less than that at day 3.
Pref-1 was higher in siMET fat pads than in siNON fat pads at all
time points.
As shown in Fig. 9 expression of TIE-1 and PECAM-1
increased over time (P  0.05) in fat pads from both siNON
and siMET preadipocytes. Importantly, TIE-1 and PECAM-1
mRNA expression in siMET fat pads was not different from
that of siNON fat pads. Vascular structures and lipid-filled
adipocytes were present in siMET fat pads at 14 days postin-
jection (Fig. 4).
Fig. 4. Confocal imaging of developing fat pads. Unfixed fat pads at 14 days
postinjection were stained with BODIPY (red) for fatty acid and isolectin
(green) for endothelial cells. Note the large adipocytes and well-developed
vasculature in the siNON fat pad (top). In contrast, mature adipocytes and
contiguous vascular structures were absent in the siHGF fat pad (middle). Fat
pads derived from preadipocytes with silencing of c-MET expression (siMET)
showed a well-developed vasculature and mature adipocytes (bottom).
Fig. 3. Markers of endothelial cell migration into developing fat pads are
reduced with silencing of preadipocyte HGF expression. In siNON fat pads,
the expression of tyrosine kinase with immunoglobulin-like and epidermal
growth factor-like domains 1 (TIE-1) and platelet endothelial cell adhesion
molecule 1 (PECAM-1) is greater at day 14 compared with day 3. Expression
of TIE-1 and PECAM-1 in siHGF fat pads is significantly less than in siNON
fat pads at day 14. Values represent means  SE for the no. of fat pads
described in Fig. 1. #P  0.05 compared with day 3 fat pad; *P  0.05
compared with siNON fat pad at that time point.
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DISCUSSION
Understanding the basic mechanisms regulating vascular
growth in adipose tissue is needed to better address the meta-
bolic dysregulation that occurs in obesity. HGF is an important
angiogenic factor in adipose tissue, facilitating communication
between preadipocytes, adipocytes, and endothelial cells. In
the present study we provide novel insight into the role of
preadipocyte HGF to promote vascular growth. Using the
3T3-F442A in vivo fat pad formation model we show that, in
the absence of preadipocyte HGF, mature fat pads fail to
develop because of impaired neovascularization, resulting in
hypoxia and attenuation of preadipocyte differentiation to
mature adipocytes. A reduction in autocrine HGF signaling,
achieved by knockdown of HGF receptor c-MET expression,
did not impair fat pad development.
When injected under the skin of nude mice, 3T3-F442A
preadipocytes differentiate into mature adipocytes in a fat pad
contained within a connective tissue pocket (1, 9, 23, 25).
Using fluorescently labeled preadipocytes, we have observed
that fat pads are derived from the injected cells (data not
shown), in agreement with the observations of Mandrup et al.
(23) using 3T3-F442A preadipocytes expressing nuclear -ga-
lactosidase. These investigators further found that preadi-
pocytes are not proliferating at 1, 2, or 4 wk after implantation,
suggesting that clonal expansion/proliferation occurs within
the first 5 days following injection under the skin. Neels et al.
(25) confirmed that preadipocytes do not differentiate into
endothelial cells and that the neovasculature of the developing
fat originates by sprouting from host-derived blood vessels.
In the present study, lentiviral-treated and clonally selected
preadipocytes with unaltered HGF expression (siNON) readily
formed fat pads in vivo, and the weight of these fat pads at day
3 and 14 was not different. In early work with this model, other
investigators described, but did not document by measuring
weight or volume, that fat pads looked smaller after injection
under the skin, then steadily became much larger at 4–6 wk
postinjection (16, 23). Our data in Fig. 7, derived from inde-
pendent fat pads excised at each time point, support the
concept that fat pads can become smaller and then expand in
size. Mechanisms that could contribute to smaller fat pads in
the period immediately after injection include loss of fluid
volume from in and around the injected cells, closer packing of
cells as extracellular matrix forms, and resorption of the
necrotic core in the center of injected cell mass (25). Con-
versely, increases in fat pad size should result from clonal
expansion of differentiating preadipocytes and accumulation of
lipid within mature adipocytes. Data in both Figs. 1 and 7
suggest that siNON fat pads were trending larger by day 14
than day 3. Longer time points postinjection (4–6 wk) would
be needed to definitively establish if fat pads become larger
over time under the conditions in our laboratory.
Preadipocytes in siNON fat pads differentiated into mature
adipocytes with significant increases in expression of PPAR
and LPL. Message levels for TIE-1 and PECAM-1, previously
shown to correlate with histological evidence of endothelial
cells in developing fat pads (1, 25), concomitantly increased as
preadipocyte differentiation occurred. Finally, confocal imag-
ing at day 14 confirmed the presence of mature lipid-filled
adipocytes and contiguous vascular structures in siNON fat
pads. These observations are in agreement with earlier work
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Fig. 5. Hypoxia-inducible factor-1	 (HIF-1	) expression is greater in fat pads
derived from siHGF preadipocytes at 3 days postinjection. Values represent
means  SE for 13 siNON and 13 siHGF fat pads. *P  0.05 compared with
siNON fat pad at that time point.
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Fig. 6. Membrane c-MET protein is reduced in preadipocytes with silencing of
c-MET expression. Relative band density: siNON 
 1,045,520; siMET 

592,098; HEK 
 2,107,784. HEK-293 cells (HEK) run as a positive control
with high c-MET expression.
Fig. 7. Preadipocytes with knockdown of c-MET expression (siMET) form
viable fat pads. siNON and siMET preadipocytes were injected under the skin
of nude mice, and developing fat pads were removed and weighed on the
indicated day postinjection. Note that siMET fat pad weight is stable across the
14-day experimental period. Values represent means  SE for n 
 7 siNON
and siMET fat pads at day 3 and 14, with n 
 7 siNON and 6 siMET fat pads
at day 7 (1 siMET pad not found). *P  0.02 compared with siNON fat pad
at that time point.
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documenting that angiogenesis and adipogenesis are interde-
pendent events in development and growth of adipose tissue
(12, 17, 18).
Fat pads derived from siHGF preadipocytes were smaller
than siNON fat pads beginning at day 3 and continued to
decrease in size across the experimental period. Expression of
PPAR and LPL in siHGF fat pads was low but, more
importantly, did not significantly increase over time. In vitro,
expression of PPAR and LPL increased 13- and 54-fold,
respectively, during differentiation of siHGF preadipocytes,
ruling out defects due to lentiviral knockdown of HGF. In
contrast, differentiation in vivo was significantly impaired,
with the lack of mature lipid-filled adipocytes contributing to
the smaller size of siHGF fat pads. TIE-1 and PECAM-1
expression was detectable in siHGF fat pads, and confocal
microscopy confirmed that endothelial cells were present; how-
ever, a functional vascular network had not formed by day 14.
These observations support our hypothesis that HGF is needed
for proper vascular development and that preadipocyte differ-
entiation depends on a functional vasculature. In support of this
interpretation, Fukumura et al. (14) observed that blocking
angiogenesis with an anti-VEGF receptor antibody impaired
differentiation of 3T3-F442A preadipocytes in a dorsal skin
fold chamber model.
Hypoxia inhibits differentiation of 3T3-L1 and 3T3-F442A
preadipocytes in vitro by promoting/maintaining expression
of Pref-1 (6, 21), a well-established inhibitor of the differen-
tiation process (32) that has also recently been shown to inhibit
preadipocyte proliferation (24, 33). Hypoxia was greater in
siHGF fat pads at 3 days postinjection as indicated by greater
HIF-1	 expression. Pref-1 was significantly greater in siHGF
fat pads than in siNON fat pads at all time points and did not
change over the 14-day experimental period. Thus, in the
absence of preadipocyte HGF, impaired neovascularization
resulted in hypoxia and maintenance of Pref-1 expression,
which inhibited clonal expansion and differentiation of pre-
adipocytes.
We noted that 4 of the 13 siHGF fat pads initiated were not
found by day 14, suggesting that siHGF preadipocytes did not
survive. Measures of endoplasmic reticulum stress (CHOP),
initiation of apoptosis (BAX), and macrophage markers
(CD68) were not different between siHGF and siNON fat pads,
providing no evidence for programmed cell death. Neels et al.
(25) provided histological evidence for resorption of the ne-
crotic core within the developing fat pad, and preadipocytes
can exhibit phagocytic properties similar to that of macro-
Fig. 8. Increased adipocyte differentiation over time in fat pads derived from
preadipocytes with c-MET knockdown. In both siNON and siMET fat pads,
expression of adipocyte markers PPAR and LPL is greater at day 14
compared with day 3. PPAR expression in siMET fat pads increased 55 
17-fold from day 3 to day 14 compared with a 5  1-fold increase in siNON
pads. The fold increase in LPL expression in siMET fat pads was similar to that
in siNON fat pads (11  4 vs. 20  7; P  0.05). Values represent the means 
SE for the no. of fat pads described in Fig. 7. #P  0.05 compared with day 3 fat
pad; *P  0.05 compared with siNON fat pad at that time point.
Fig. 9. The increase in endothelial cell markers over time in fat pads derived
from preadipocytes with c-MET knockdown is the same as that in fat pads
from control preadipocytes. In both siNON and siMET fat pads, expression of
TIE-1 and PECAM-1 is greater at day 14 compared with day 3. Values
represent means  SE for the no. of fat pads described in Fig. 7. #P  0.05
compared with day 3 fat pad.
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phages (7, 10, 11). Thus it is possible that siHGF preadipocytes
became necrotic and were resorbed. Alternatively, preadi-
pocytes may have been difficult to see and physically separate
from the host tissue because they had not undergone clonal
expansion to increase cell number, or differentiated and filled
with lipid. Future studies employing siHGF preadipocytes with
a visual tag or stain will be needed to fully address this
possibility.
HGF is not only a potent angiogenic factor acting on
endothelial cells but also promotes growth and survival of
other cell types (15). Preadipocytes express the HGF receptor
c-MET, and HGF has been shown to stimulate glucose uptake
in 3T3-L1 adipocytes (3). Furthermore, in a study injecting
adipose-derived stem cells with HGF knockdown into ischemic
hind limbs, it was noted that loss of HGF expression reduced
survival of the injected cells (4). Thus we addressed the
question whether autocrine/paracrine HGF signaling was re-
quired for fat pad development.
At 3 days postinjection, fat pads derived from siMET pre-
adipocytes were smaller than siNON fat pads. However, in
contrast to the progressive decrease in size observed with
siHGF fat pads, the weight of the siMET fat pads remained
constant over the 14-day experiment. PPAR, LPL, TIE-1, and
PECAM-1 expression increased over time, and Pref-1 de-
creased over time, indicating that preadipocytes were differen-
tiating and endothelial cells were migrating into the developing
fat pad. Confocal microscopy confirmed the presence of ma-
ture adipocytes and capillary structures, indicating that loss of
autocrine/paracrine HGF signaling in preadipocytes did not
significantly impair development of functional fat pads. The
finding that Pref-1 was greater in siMET than siNON fat pads
suggests that preadipocytes remained or that adipocytes were
not fully mature, which may have contributed to the slightly
smaller size of the siMET fat pads. A difference in extracel-
lular matrix formation, size of the necrotic core, or amount of
lipid contained in the mature adipocytes may also have con-
tributed to smaller siMET fat pads.
It is important to note that c-MET protein was only reduced
44%. Thus it is possible that greater c-MET knockdown may
have revealed a larger role for autocrine HGF signaling in fat
pad development. siMET preadipocytes also secreted greater
amounts of HGF than did siNON or siHGF preadipocytes,
possibly because of loss of feedback with reduced c-MET
abundance. Increased HGF secretion may have had a compen-
satory effect to promote fat pad development in these experi-
ments.
We have previously shown that adipocytes from obese
humans secrete more HGF than adipocytes from lean subjects
(2), and observations in the current study provide strong
evidence for preadipocyte HGF to promote vascular develop-
ment in adipose tissue. Given these findings, it is not clear why
adipose tissue HGF does not prevent hypoxia or rarefaction in
obesity. One possibility is that cytokines or other factors in the
adipose tissue act on the endothelial cells to block the effect of
HGF to promote or maintain vascular development in obesity.
An alternate hypothesis is that elevated HGF in adipose tissue
of obese subjects has a strong protective effect on the vascu-
lature, and that, if this angiogenic factor were not present,
vascular defects and hypoxia would be even more pronounced.
Transgenic mouse models with adipose tissue-specific knock-
out of HGF expression will be needed to fully address this
point.
Two limitations of this study deserve mention. We demon-
strated that silencing HGF expression impaired fat pad devel-
opment but did not do functional rescue by transfection to
restore HGF expression. However, we did use a scrambled
shRNA control cell line to account for the effects of lentiviral
treatment and antibiotic selection. Furthermore, targeting c-MET
did not impair development of fat pads as observed when target-
ing HGF, strengthening the likelihood that effects were specific to
HGF knockdown. Second, we could not fully differentiate be-
tween inhibition of clonal expansion and resorption of necrotic
preadipocytes as the main cause for progressively smaller, and in
some cases absent, siHGF fat pads. Future experiments with
lineage-specific tags and direct measures of preadipocyte prolif-
eration will be needed to fully resolve the fate of siHGF preadi-
pocytes.
In summary, our data strongly support a role for HGF in the
regulation of adipose tissue vascular growth. We show that loss
of preadipocyte HGF expression significantly attenuates neo-
vascularization in developing fat pads, resulting in impaired
differentiation of preadipocytes to mature adipocytes. Loss of
autocrine HGF signaling did not impair development of func-
tional fat pads. Understanding the interaction of preadipocytes
and adipocytes with the adipose tissue vasculature should
provide important insight into the mechanisms contributing to
metabolic dysregulation in obesity.
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